PureCycle Technologies, Inc. (PCT) - Q1 2025 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended March 31, 2025. PureCycle Technologies, Inc. is a Florida-based corporation commercializing a patented dissolution recycling technology to convert waste polypropylene into PureFive™ resin. The company operates a commercial-scale facility in Ironton, Ohio (Ironton Facility), which is currently in the commissioning phase, and is developing a multi-line facility in Augusta, Georgia. The company reported its first quarterly revenues of approximately $1.6 million in Q1 2025.
Key Financial Metrics
| Metric | Q1 2025 | Q1 2024 |
|---|---|---|
| Revenues | $1.58 million | $0 |
| Net Income/(Loss) | $8.83 million | $(85.61) million |
| Operating Loss | $(37.72) million | $(38.98) million |
| Cash and Cash Equivalents | $22.48 million | $25.02 million |
| Restricted Cash | $14.98 million | $24.92 million |
| Total Debt (Gross) | $363.39 million | $346.64 million |
| Working Capital Deficit | $(40.95) million | $(36.98) million |
Note: Net income for Q1 2025 was driven primarily by a $56.7 million non-cash gain from the change in fair value of warrant liabilities and a $3.1 million gain from the change in fair value of a preferred stock put option.
Material Changes vs. Prior Period
- Revenue Generation: The company recorded $1.58 million in revenue, marking the first period of meaningful sales, compared to zero revenue in Q1 2024.
- Profitability: The company swung from a net loss of $85.61 million in Q1 2024 to a net income of $8.83 million in Q1 2025. This improvement is largely attributable to a $70.6 million swing in the "Change in fair value of warrants" line item (from a $13.9M loss to a $56.7M gain) and the absence of a $21.2 million loss on debt extinguishment recorded in the prior year.
- Operating Expenses: Total operating expenses increased slightly to $39.30 million from $38.98 million. Cost of operations rose by $2.1 million due to production ramp-up, while SG&A decreased by $1.5 million primarily due to lower legal costs.
- Liquidity: Unrestricted cash increased to $22.5 million from $15.7 million at year-end 2024, supported by a $33.0 million private placement of common stock in February 2025 and $16.4 million in proceeds from the sale of revenue bonds in March 2025.
Guidance, Outlook, Risks, and Contingencies
- Going Concern: Management has historically raised substantial doubt about the company's ability to continue as a going concern due to recurring losses and negative cash flows. However, management believes this doubt has been alleviated by recent capital raises, the availability of a $200 million revolving credit facility (extended to September 2026), and plans to re-market outstanding revenue bonds.
- Operational Outlook: The Ironton Facility is working to improve operating rates, reliability, and product quality. Numerous customer trials are ongoing, but the timing and success of future orders remain uncertain. The Augusta Facility is in the early works construction phase.
- Legal Proceedings:
- Derivative Litigation: A consolidated derivative lawsuit was settled in May 2025 for $3.0 million, funded by D&O insurance. The court granted final approval.
- Securities Litigation: A shareholder securities class action (Southgate) was dismissed with prejudice in January 2025.
- Arbitration: An arbitration with Denham-Blythe Company, Inc. regarding the Ironton Facility construction is ongoing, with discovery in progress. The company cannot currently estimate the potential loss.
- Debt Covenants: The company has amended various debt instruments, including Revenue Bonds and the Sylebra Credit Facility, to extend maturity dates and adjust covenants. The company must meet specific coverage ratios and cash-on-hand requirements starting in fiscal year 2026.
Investor Verification Checklist
- Revenue Sustainability: Verify the durability of the $1.6 million revenue run rate and the status of customer qualification trials.
- Non-GAAP Adjustments: Scrutinize the $56.7 million warrant fair value gain and $3.1 million put option gain, as these are non-cash items that significantly distort net income.
- Liquidity Runway: Assess the sufficiency of the $22.5 million unrestricted cash balance against the $56.0 million in debt service and equipment payments due within one year.
- Debt Structure: Review the terms of the $200 million Sylebra Revolving Credit Facility (interest rate of SOFR + 17.5%) and the ability to re-market the $99.0 million of outstanding revenue bonds.
- Legal Exposure: Monitor the outcome of the Denham-Blythe arbitration, which could result in significant damages.